This company listing is no longer active
aXichem Valuation
Is AXIC A BTA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AXIC A BTA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AXIC A BTA (SEK7) is trading below our estimate of fair value (SEK17.7)
Significantly Below Fair Value: AXIC A BTA is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AXIC A BTA?
Other financial metrics that can be useful for relative valuation.
What is AXIC A BTA's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | kr153.91m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 33.2x |
Enterprise Value/EBITDA | -15x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does AXIC A BTA's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 10.8x | ||
AERO Svenska Aerogel Holding | 26.4x | 54.2% | kr82.2m |
PCAT Photocat | 2.8x | n/a | kr72.5m |
ITECH I-Tech | 4.6x | 16.7% | kr559.7m |
PREBON Prebona | 9.2x | n/a | kr92.6m |
AXIC A BTA aXichem | 30.7x | 109.0% | kr153.9m |
Price-To-Sales vs Peers: AXIC A BTA is expensive based on its Price-To-Sales Ratio (30.7x) compared to the peer average (13.5x).
Price to Earnings Ratio vs Industry
How does AXIC A BTA's PE Ratio compare vs other companies in the European Chemicals Industry?
Price-To-Sales vs Industry: AXIC A BTA is expensive based on its Price-To-Sales Ratio (30.7x) compared to the European Chemicals industry average (1.2x)
Price to Sales Ratio vs Fair Ratio
What is AXIC A BTA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 30.7x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate AXIC A BTA's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.